Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Wesana Health Holdings Inc. (C:WESA)

Business Focus: Biotechnology & Medical Research

Jul 16, 2021 07:30 am ET
Ian Burnstein Joins Wesana Health Board of Directors
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance,...
Jul 14, 2021 08:30 am ET
Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The Transactions
Mycotopia Therapies, Inc., (OTC Pink: TPIA) ("Mycotopia" or the “Company”) announced today that on July 13, 2021 Wesana Health Holdings Inc. (“Wesana”) (CSE: WESA) announced the execution of a definitive agreement to acquire Psychedelitech Inc.,...
Jul 14, 2021 07:30 am ET
Ian Burnstein Joins Wesana Health Advisory Board
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance,...
Jul 13, 2021 09:07 am ET
IIROC Trade Resumption - WESA
VANCOUVER, BC, July 13, 2021 /CNW/ - Trading resumes in:
Jul 13, 2021 08:58 am ET
Wesana Health Announces Definitive Agreement to Acquire PsyTech Inc.
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance, including...
Jul 13, 2021 08:58 am ET
IIROC Trading Halt - WESA
VANCOUVER, BC, July 13, 2021 /CNW/ - The following issues have been halted by IIROC:
Jun 24, 2021 04:05 pm ET
Wesana Health Partners with University of South Carolina
Wesana Health Holdings Inc. (“Wesana” or the "Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance,...
Jun 16, 2021 08:30 am ET
CSE Reports Strong Listings Growth in May 2021 Including a Landmark IPO
Toronto, Ontario--(Newsfile Corp. - June 16, 2021) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced its market statistics for the month of May 2021. The month was highlighted by near-record growth in listings.
Jun 01, 2021 07:37 am ET
Wesana Announces Participation at Upcoming Events in June 2021
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance,...
May 27, 2021 08:57 am ET
Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance,...
May 21, 2021 07:45 am ET
Wesana Health Expands Research Leadership Team with Mark Wingertzahn, PhD as Chief Scientific Officer
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data-driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance,...
May 13, 2021 07:30 am ET
The World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain Injury
The World Boxing Council (“WBC”), boxing’s elite sanctioning body, and Wesana Health Holdings Inc. (“Wesana”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding,...
May 10, 2021 07:30 am ET
Wesana Health Commences Trading on the CSE
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), formerly Debut Diamonds Inc., is pleased to announce that its shares will commence trading on the Canadian Securities Exchange (“CSE”) today, Monday, May 10, 2021 under the ticker...